George Magrath - May 17, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: Chief Executive Officer
Signature: /s/ Amy Rabourn, by Power of Attorney
Stock symbol: OCUP
Transactions as of: May 17, 2024
Transactions value $: $8,773
Form type: 4
Date filed: 5/21/2024, 04:18 PM
Previous filing: Mar 20, 2024
Next filing: Nov 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Purchase	$8.77K	+5K	+1.18%	$1.75	430K	May 17, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.73 to $1.78, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.73 to $1.78, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.